Source: MarketScreener

ObsEva: ObsEva Announces Update on Board of Directors

(marketscreener.com) Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland - March 18, 2024 - ObsEva SA , a biopharmaceutical company developing and commercializing novel therapies for women's health, today announced that, concurrent to the decision to wind-down the company's operations, Catarina...https://www.marketscreener.com/quote/stock/OBSEVA-153872618/news/ObsEva-Announces-Update-on-Board-of-Directors-46227256/?utm_medium=RSS&utm_content=20240319

Read full article »
Annual Revenue
$5.0-25M
Employees
1-25
Fabien de Ladonchamps's photo - CEO of ObsEva

CEO

Fabien de Ladonchamps

CEO Approval Rating

82/100

Read more